Enhanced gastrointestinal absorption of N3-O-toluylfluorouracil by cationic solid lipid nanoparticles

Journal of Nanoparticle Research

Volumn 12, Issue 3, 2010, Pages 975-984

  Liu, Donghua ^a   Liu, Chunxi ^a   Zou, Weiwei ^a   Zhang, Na ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Bioadhension nano oral drug delivery system; Cationic solid lipid nanoparticles; In situ intestinal absorption; N3 O toluyl fluorouracil; Nanomedicine

Indexed keywords

FLUOROURACIL; IN-SITU; INTESTINAL ABSORPTION; NANOMEDICINES; ORAL DRUG DELIVERY SYSTEM; SOLID LIPID NANOPARTICLES;

ABSORPTION; BIOCHEMISTRY; BODY FLUIDS; BROMINE COMPOUNDS; DRUG PRODUCTS; ENCAPSULATION; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; PHARMACOKINETICS; ZETA POTENTIAL;

CONTROLLED DRUG DELIVERY;

BROMINE DERIVATIVE; FLUOROURACIL DERIVATIVE; N2 O TOLUYL FLUOROURACIL; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; COLLOID; CONTROLLED STUDY; DIFFUSION; DISPERSION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DUODENUM; ENCAPSULATION; GASTROINTESTINAL ABSORPTION; IN VITRO STUDY; IN VIVO STUDY; JEJUNUM; MALE; MORPHOLOGY; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; STOMACH JUICE; ZETA POTENTIAL;

EID: 77953249458     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-009-9648-4     Document Type: Article

References (36)

1. Armstrong NA, James KC (1980) Drug release from lipidbased dosage forms II. Int J Pharm 6:195-204. doi: 10.1016/0378-5173(80)90104-0 (Pubitemid 11161709)
2. Charman WN, Porter CJH, Mithani S et al (1997) Physicochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J Pharm Sci 86:269-282. doi:10.1021/js960085v (Pubitemid 27113759)
3. Cui J, Zhai GX, Zhao Y et al (2009) Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm 371:148-155. doi: 10.1016/j.ijpharm.2008.12.009
4. Elbaz E, Zeevi A, Klang S et al (1993) Positively charged submicron emulsions-a new type of colloidal drug carrier. Int J Pharm 96:R1-R6. doi:10.1016/0378-5173(93)90237-A
5. El-Shabouri MH (2002) Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. Int J Pharm 249:101-108. doi:10.1016/S0378-5173(02)00461-1 (Pubitemid 35333436)
6. Garcia-Fuentes M, Torres D, Alonso MJ (2005) New surfacemodified lipid nanoparticles as delivery vehicles for salmon calcitonin. Int J Pharm 296:122-132. doi:10.1016/j.ijpharm.2004.12.030 (Pubitemid 40693381)
7. Gershanik T, Benita S (1996) Positively charged self-emulsifying oily formulation for improving oral bioavailability of progesterone. Pharm Dev Technol 1:147-157. doi: 10.3109/10837459609029889
8. Gershanik T, Benita S (2000) Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs.Eur J Pharm Sci Biopharm 50:179-188. doi:10.1016/S0939-6411(00)00089-8 (Pubitemid 30326696)
9. Gershanik T, Haltner E, Lehr CM et al (2000) Charge-dependent interaction of self-emulsifying oily formulations with Caco-2 cells monolayers: binding effects on barrier function and cytotoxicity. Int J Pharm 211:29-36. doi:10.1016/S0378-5173(00)00591-3 (Pubitemid 32008381)
10. Glavas-Dodov M, Fredro-Kumbaradzi E, Goracinova K et al (2005) The effects of lyophilization on the stability of liposomes containing 5-FU. Int J Pharm 291:79-86. doi: 10.1016/j.ijpharm.2004.07.045 (Pubitemid 40221999)
11. Guo LSS, Radhakrishnan R, Redemann CT (1989) Adhesion ofpositively charged liposomes to mucosal tissues. J Liposome Res 1:319-337. doi:10.3109/08982108909036000
12. Gursoy RN, Benita S (2004) Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilicdrugs. Biomed Pharmacother 58:173-182. doi: 10.1016/j.biopha.2004.02.001 (Pubitemid 38479922)
13. Gutierro I, Hernandez RM, Igartua M et al (2002) Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres. Vaccine 21:67-77. doi:10.1016/S0264-410X(02)00435-8 (Pubitemid 35351352)
14. Humberstone AJ, Charman WN (1997) Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliv Rev 25:103-128. doi:10.1016/S0169-409X(96)00494-2
15. Lee M, Choi L, Kim M et al (1999) Pharmacokinetics and organ distribution of cyclosporin A incorporated in liposomes and mixed micelles. Int J Pharm 191:87-93. doi:10.1016/S0378-5173(99)00260-264
16. Li Q, Feng FY, Han J et al (2002) Phase III clinical study of a new anticancer drug atofluding. Ai Zheng 21:1350-1353
17. Li HL, Zhao XB, Ma YK et al (2009) Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J Control Release 10:238-244. doi:10.1016/j.jconrel.2008.10.002
18. Liu J, Zhu J, Du Z et al (2005) Preparation and pharmacokinetic evaluation of Tashinone IIA solid lipid nanoparticles. Drug Dev Ind Pharm 31:551-556. doi:10.1080/03639040500214761 (Pubitemid 41285733)
19. Liu J, Li X, Cheng YN et al (2007) Inhibition of human gastric carcinoma cell growth by treatment of N(3)-o-toluyl-fluorouracil as a precursor of 5-fluorouracil. Eur J Pharmacol 574:1-7. doi:10.1016/j.ejphar.2007.06.064 (Pubitemid 47503158)
20. Liu Y, Zhang P, Feng NP et al (2009) Optimization and in situ intestinal absorption of self-microemulsifying drug delivery system of oridonin. Int J Pharm 365:136-142. doi:10.1016/j.ijpharm.2008.08.009
21. Lu B, Xiong SB, Yang H et al (2006) Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases. Eur J Pharm Sci 28:86-95. doi:10.1016/j.ejps.2006.01.001
22. Luo YF, Chen DW, Ren LX et al (2006) Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J Control Release 114:53-59. doi:10.1016/j.jconrel.2006.05.010
23. Porter CJH, Trevaskis NL, Charman WN (2007) Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov 6:231-248. doi: 10.1038/nrd2197 (Pubitemid 46344627)
24. Pouton CW (2006) Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the Lipid Formulation Classification System. Eur J Pharm Sci 29:278-287. doi:10.1016/j.ejps.2006.04.016 (Pubitemid 44740131)
25. Priano L, Esposti D, Esposti R et al (2007) Solid lipid nanoparticles incorporating melatonin as new model for sustained oral and transdermal delivery systems. J Nanosci Nanotechnol 7:3596-3601. doi:10.1166/jnn.2007.809
26. Sarmento B, Martins S, Ferreira D et al (2007) Oral insulin delivery by means of solid lipid nanoparticles. Int J Nanomed 2:743-749
27. Sun WT, Zhang N, Li AG et al (2008) Preparation and evaluation of N3-O-toluyl-fluorouracil-loaded liposomes. Int J Pharm 353:243-250. doi:10.1016/j.ijpharm.2007.11.017
28. Sunesen VH, Vedesdal R, Kristensen HG et al (2005) Effect of liquid volume and food intake on the absolute bioavailability of danazol, a poorly soluble drug. Eur J Pharm Sci 24:297-303. doi:10.1016/j.ejps.2004.11.005 (Pubitemid 40283512)
29. Teixeira H, Dubernet C, Puisieux F et al (1999) Submicron cationic emulsions as a new delivery system for oligonucleotides.Pharm Res 16:30-36. doi:10.1023/A:1018806425667 (Pubitemid 29047453)
30. Uner M (2006) Preparation, characterization and physicochemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems. Pharmazie 61:375-386
31. Urata T, Arimori K, Nakano N (1999) Modification of the release rate of cyclosporin A from polyl(L-lactic acid)microspheres by fatty acid ester and in vivo evaluation of the microspheres. J Control Release 58:133-141. doi: 10.1016/S0168-3659(98)00146-1 (Pubitemid 29112884)
32. Vasir JK, Tambwekar K, Garg S (2003) Bioadhesive microspheres as a controlled drug delivery system. Int J Pharm255:13-32. doi:10.1016/S0378- 5173(03)00087-5 (Pubitemid 36369587)
33. Venkataram S, Awni WM, Jordan K et al (1990) Pharmacokinetics of two alternative dosage forms of cyclosporin: liposomes and intralipid. J Pharm Sci 79:216-219. doi: 10.1002/jps.2600790307
34. Welling PG (1996) Effects of food on drug absorption. Annu Rev Nutr 16:383-415. doi:10.1146/annurev.nu.16.070196.002123
35. Wu YN, Luan LB (2008) In situ rats single pass perfusion intestinal absorption of the effectivein components in Radix Angelicae Pubescentis. Yao Xue Xue Bao 43:102-107
36. Yanagawa A, Iwayama T, Saotome T et al (1989) Selective transfer of cyclosporin to thoracic lymphatic systems by the application of lipid microspheres. J Microencapsul 6:161-164. doi:10.3109/02652048909098016